USFD enters the week after Q1 results carrying its worst five-day loss in months — the stock closed at $84.40 on Friday, down 9.3% on the week and 2.9% in the final session alone. A Q1 earnings miss, blamed on elevated fuel costs and adverse weather, cracked a stock that had been running up all year. The drop triggered a fresh wave of short-seller interest and a rapid analyst target-price reassessment.
The week's most notable analyst action came from Citigroup's Karen Holthouse, who maintained a Buy rating but cut her price target from $115 to $111 on May 8 — the day after results. That remains well above where the stock is trading, implying roughly 32% upside from current levels. The broader analyst community is still firmly constructive. The consensus mean target of ~$108 gives USFD nearly 28% return potential at current prices. Most prior-quarter target raises — from Barclays, Wells Fargo, BMO Capital and Guggenheim, all in February — have not been formally revised following the Q1 miss, though those updates predate the latest weakness. Piper Sandler stands as the lone recent downgrader, cutting to Neutral back in February. The Street's message is that execution risk is rising, not that the thesis is broken.
Short sellers used the post-earnings drop to quietly rebuild positions. SI climbed 5.6% over the past week to 4.2% of the float — still a modest absolute level but a meaningful directional shift. The move follows a period of gradual decline through late April. Borrow conditions remain undemanding: cost to borrow is a low 0.53% and has edged up just 3.4% on the week. Availability is ample, consistent with a stock where incremental shorts are easy to put on. This is not a squeeze setup. Days to cover sits near 6, suggesting the short base is not yet large enough to present a self-reinforcing risk. The ORTEX short score of 40.5 — rising from around 39 a week ago but still comfortably below any extreme threshold — reflects the same picture: shorts building, but not crowding.
Options sentiment has actually turned more constructive in the aftermath of results. The put/call ratio fell to 0.68 on Friday, below its 20-day average of 0.75. That stands in contrast to April, when the PCR briefly touched 1.6 — the most defensively positioned the options market had been in months. The collapse in that hedging premium after the earnings print suggests that investors who bought protection into results have since closed those positions. It does not indicate fresh bullishness, but the fear trade is off.
Company management reaffirmed its full-year 2026 outlook for 9–13% adjusted EBITDA growth following the Q1 miss. That guidance hold is the central debate for the bulls. Q1 headwinds — fuel costs, weather disruption — are framed as transitory. EPS momentum factors score in the 67th–69th percentile, indicating the Street still sees improving estimates over the coming months. The EV/EBITDA multiple has compressed around 0.6 turns over the past 30 days to 11.2x — cheaper than it was, but not yet cheap in absolute terms. The P/E ratio has shed about 1.3 turns over the same period to 17.1x. The RSI14 has dropped to 33, nudging toward oversold territory — a level that historically attracts mean-reversion buyers in a stock with institutional ownership this concentrated. Vanguard, BlackRock, Boston Partners and Wellington collectively hold over 30% of shares.
The next Q2 earnings event is flagged for May 14. Q1 landed with an 8.3% single-day decline. The Q4 2025 release triggered a 4.8% drop. Whether the guidance hold proves durable — against a backdrop of persistent fuel cost pressure and a potentially softening restaurant industry — is where the Q2 conversation will start.
See the live data behind this article on ORTEX.
Open USFD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
